Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

mTOR kinase structure, mechanism and regulation

Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP · 2013 · Nature · Atlas ID YAN2013

What this study shows

Solved the crystal structure of the mTOR kinase itself. Revealed why the active site is so hard to reach - it sits in a deep recess guarded by the FRB domain, which acts as a 'gatekeeper' letting substrates in. This structure explains at the atomic level exactly how FKBP12-rapamycin blocks access, and why activating cancer mutations cluster where they do.

Abstract

ShowHide

The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer. Here we report co-crystal structures of a complex of truncated mTOR and mammalian lethal with SEC13 protein 8 (mLST8) with an ATP transition state mimic and with ATP-site inhibitors. The structures reveal an intrinsically active kinase conformation, with catalytic residues and a catalytic mechanism remarkably similar to canonical protein kinases.

Read the full abstract on PubMed →

At a glance

Evidence type M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: X-ray crystallography (structural biology)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is.
Study type5 - Mechanistic / In Vitro
Model systemX-ray crystallography (structural biology)
JournalNature
Year2013
Peer reviewedYes
Record last updated2026-08-22
SourceDOI 10.1038/nature12122 · PMID 23636326 · Free full text (PMC4512754)

Extracted findings

InterventionStructural (X-ray crystallography)
TargetmTOR / mLST8
ModelX-ray crystallography
EffectCo-crystal structures reveal mTOR's intrinsically active kinase and how ATP-site inhibitors bind

In the Atlas

Related topics

RapamycinmTORFKBP12

More studies on this topic

Cite this paper

ShowHide
Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., & Pavletich, N. P. (2013). mTOR kinase structure, mechanism and regulation. Nature. https://doi.org/10.1038/nature12122

@article{YAN2013,
  author       = {Yang, H. and Rudge, D. G. and Koos, J. D. and Vaidialingam, B. and Yang, H. J. and Pavletich, N. P.},
  title        = {{mTOR kinase structure, mechanism and regulation}},
  journal      = {Nature},
  year         = {2013},
  doi          = {10.1038/nature12122},
  note         = {PMID: 23636326},
}

Cite this Atlas record

The record is the Atlas's own work — the evidence label, the extracted findings and the links. It is cited as part of the dataset, not as the paper.

Barton, O. (2026). Oliver's mTOR Atlas (record YAN2013) [Data set]. https://mtor-atlas.org/study/YAN2013/ · Dataset DOI 10.5281/zenodo.22059963

@misc{atlas_YAN2013,
  author       = {Barton, Oliver},
  title        = {{Oliver's mTOR Atlas}, record YAN2013},
  howpublished = {Data set},
  year         = {2026},
  url          = {https://mtor-atlas.org/study/YAN2013/},
  doi          = {10.5281/zenodo.22059963}
}